| Matever 750 mg film-coated tablets EU/1/11/711/015-022 |
Levetiracetam |
Pharmathen S.A. |
— |
| Matrifen 100 micrograms/hour Transdermal patch PA25340/001/005 |
Fentanyl |
Istituto Gentili S.r.l. |
Marketed |
| Matrifen 12 micrograms/hour Transdermal patch PA25340/001/001 |
Fentanyl |
Istituto Gentili S.r.l. |
Marketed |
| Matrifen 25 micrograms/hour Transdermal patch PA25340/001/002 |
Fentanyl |
Istituto Gentili S.r.l. |
Marketed |
| Matrifen 50 micrograms/hour Transdermal patch PA25340/001/003 |
Fentanyl |
Istituto Gentili S.r.l. |
Marketed |
| Matrifen 75 micrograms/hour Transdermal patch PA25340/001/004 |
Fentanyl |
Istituto Gentili S.r.l. |
Marketed |
| MAVENCLAD 10 mg tablets EU/1/17/1212/001-006 |
Cladribine |
Merck Europe B.V. |
— |
| Maviret 100 mg/40 mg film-coated tablets EU/1/17/1213/001 |
Pibrentasvir, Glecaprevir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maviret 50 mg/20 mg coated granules in sachet EU/1/17/1213/003 |
Glecaprevir, Pibrentasvir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maxeeze Effervescent Tablets Paracetamol 500 mg Codeine Phosphate Hemihydrate 8 mg Caffeine 30 mg PA1701/016/001 |
Paracetamol, Codeine phosphate bp, Caffeine |
Zentiva k.s. |
Marketed |
| Maxibar 98.45% w/w powder for oral suspension PA1826/002/001 |
Barium sulfate |
Bracco Imaging spa |
Marketed |
| Maxidex 0.1% w/v Eye Drops, Suspension PA0896/018/001 |
Dexamethasone |
Novartis Ireland Limited |
Marketed |
| Maxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspension PA0896/019/001 |
Dexamethasone, Polymyxin b sulfate, Neomycin sulfate |
Novartis Ireland Limited |
Not marketed |
| Maxolon 10 mg Tablets PA1142/011/003 |
Metoclopramide hydrochloride |
Amdipharm Limited |
Marketed |
| Maxolon 5 mg/ml Solution for Injection PA1142/011/001 |
Metoclopramide hydrochloride |
Amdipharm Limited |
Not marketed |
| Mayzent 0.25 mg film-coated tablets EU/1/19/1414/001-002 |
Siponomid, SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mayzent 1 mg film-coated tablets EU/1/19/1414/007-008 |
SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mayzent 2 mg film-coated tablets EU/1/19/1414/003 |
Siponomid, SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| mCOMBRIAX dispersion for injection in pre-filled syringe. Influenza and COVID-19, mRNA vaccine. EU/1/26/2028/001-002 |
mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein, mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein, mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein, mRNA-1283 |
Moderna Biotech Spain S.L. |
— |
| Mebeverine hydrochloride 135 mg Film-coated Tablets PA22871/006/001 |
Mebeverine hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Medical Air PA0208/009/001 |
Oxygen |
BOC Gases Ireland Ltd |
Marketed |
| Medical Carbon Dioxide PA0208/006/001 |
Carbon dioxide |
BOC Gases Ireland Ltd |
Marketed |
| Medical Liquid Oxygen PA0208/002/001 |
Oxygen |
BOC Gases Ireland Ltd |
Marketed |
| Medical Liquid Oxygen 100% Medicinal gas, cryogenic PA22852/001/002 |
Oxygen |
Air Liquide Healthcare Ireland Limited |
Not marketed |
| Medical Nitrous Oxide PA0208/001/001 |
Nitrous oxide |
BOC Gases Ireland Ltd |
Marketed |
| Medical Oxygen PA0208/003/001 |
Oxygen |
BOC Gases Ireland Ltd |
Marketed |
| Medical Oxygen PA22852/001/001 |
Oxygen |
Air Liquide Healthcare Ireland Limited |
Marketed |
| Medical Oxygen 100% Medicinal gas, compressed PA1848/005/003 |
Oxygen |
SOL S.p.A. |
Marketed |
| Medical Oxygen/Carbon Dioxide mixtures PA0208/004/001 |
Oxygen, Carbon dioxide |
BOC Gases Ireland Ltd |
Marketed |
| Medicinal air synthetic SOL 21.75% v/v medicinal gas, compressed PA1848/002/001 |
Oxygen |
SOL S.p.A. |
— |
| Medijel oromucosal gel Lidocaine hydrochloride 0.66% w/w Aminoacridine hydrochloride 0.05% w/w PA1113/022/001 |
Aminacrine hydrochloride, Lignocaine hydrochloride |
Phoenix Labs |
Marketed |
| Medikinet 10 mg tablets PA1555/001/007 |
Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet 20 mg tablets PA1555/001/008 |
Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet 5 mg tablets PA1555/001/006 |
Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet MR 10mg modified – release capsules, hard PA1555/001/002 |
Methylphenidate hydrochloride, Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet MR 20mg modified – release capsules, hard PA1555/001/003 |
Methylphenidate hydrochloride, Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet MR 30mg modified – release capsules, hard PA1555/001/004 |
Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet MR 40mg modified – release capsules, hard PA1555/001/005 |
Methylphenidate hydrochloride, Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medikinet MR 5mg modified – release capsules, hard PA1555/001/001 |
Methylphenidate hydrochloride, Methylphenidate hydrochloride |
Medice Arzneimittel Putter GmbH & Co. K.G |
Marketed |
| Medisils Intensive 8.75 mg lozenges PA0126/405/001 |
Flurbiprofen |
Clonmel Healthcare Ltd |
Not marketed |
| Medispray oromucosal spray, solution, Chlorhexidine digluconate 2 mg/ml, Lidocaine hydrochloride monohydrate 0.5 mg/ml PA0126/300/001 |
Lidocaine hydrochloride, Chlorhexidine digluconate |
Clonmel Healthcare Ltd |
— |
| Medithyme Cough Syrup TR0126/319/001 |
|
Clonmel Healthcare Ltd |
Marketed |
| MEFAC 250 mg hard capsules PA0074/015/001 |
Mefenamic acid |
Rowa Pharmaceuticals Limited, |
Not marketed |
| MEFAC 500 mg Film-coated tablets PA0074/015/002 |
Mefenamic acid |
Rowa Pharmaceuticals Limited |
Marketed |
| Megace 160 mg tablets PA22698/028/001 |
Megestrol acetate |
Bausch Health Ireland Limited |
Marketed |
| Megace 160 mg tablets PPA0465/323/002 |
Megestrol acetate |
PCO Manufacturing Ltd. |
— |
| Megace 160 mg Tablets PPA1463/191/001 |
Megestrol acetate |
IMED Healthcare Ltd. |
— |
| Megace 40 mg/ml oral suspension PPA0465/323/001 |
Megestrol acetate |
PCO Manufacturing Ltd. |
— |
| Megace 40 mg/ml oral suspension PPA2306/016/001 |
Megestrol acetate |
Originalis B.V. |
— |
| Megace 40 mg/ml Oral Suspension PA22698/024/001 |
Megestrol acetate |
Bausch Health Ireland Limited |
Not marketed |